Kate Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Kate Therapeutics's estimated annual revenue is currently $4.3M per year.
Employee Data
Kate Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, Co-Founder | Reveal Email/Phone |
2 | Co-Founder, SVP Nonclinical Development | Reveal Email/Phone |
3 | SVP Nonclinical, Co-Founder | Reveal Email/Phone |
4 | Co-Founder and Chief Scientific Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | SVP | Reveal Email/Phone |
8 | VP Clinical Development | Reveal Email/Phone |
9 | SVP CMC Tech Ops | Reveal Email/Phone |
10 | Associate Director, Lab Operations | Reveal Email/Phone |
Kate Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Kate Therapeutics?
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.
keywords:N/A
N/A
Total Funding
N/A
Number of Employees
$4.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator